Adolescent Thrombosis: Etiology, Prophylaxis and the Role of Hormonal Therapy
To view this Webinar, please scroll down to the bottom of the page.
This is a recorded version of our webinar on Adolescent Thrombosis presented by Dr. Lakshmi Srivaths and Dr. Jennifer E. Dietrich that took place on May 2, 2016. This webinar was jointly sponsored by the Creighton University Health Sciences Continuing Education program and the Foundation for Women & Girls with Blood Disorders.
This Webinar will provide evidence-based, practical information on the complications of thromboembolism among female adolescents. It will also review the prevalence and presentation of risk factors predisposing adolescents to VTE and discuss prophylactic strategies. Lastly, it will inform medical providers on the role of hormonal therapy and the importance of a collaborative management by hematology and gynecology for thrombosis, thrombophilia and hormonal therapy in adolescent females.
After completing this educational activity and the post-test, participants should be able to:
- Review the epidemiology of thromboembolism (TE) in adolescents and specifically female adolescents
- Review the prevalence and presentation of risk factors predisposing to adolescent TE
- Review the situations in which girls and adolescents with thrombophilia present with gynecologic concerns
- Discuss gynecologic bleeding complications in female adolescents on anticoagulants
- Discuss how thrombophilia impacts hormonal choice
- Discuss the prophylactic strategies in adolescent VTE
- Recognize the need and apply the model for collaboration among hematologists, gynecologists and other specialists for comprehensive care of adolescent TE
Lakshmi V. Srivaths, MD
Department of Pediatrics, Section of Hematology/Oncology
Young Women's Bleeding Disorder Clinic
Texas Children's Hospital / Baylor College of Medicine